Report ID |
59142 |
Drug Identification Number |
02468425 |
Brand name |
SHINGRIX |
Common or Proper name |
Herpes Zoster vaccine |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
Strength(s) |
50MCG |
Dosage form(s) |
SUSPENSION |
Route of administration |
INTRAMUSCULAR |
Packaging size |
1's |
ATC code |
J07BK |
ATC description |
|
Reason for shortage |
Other (Please describe in comments) |
Anticipated start date |
|
Actual start date |
2018-08-24 |
Estimated end date |
|
Actual end date |
2020-06-17 |
Shortage status |
Resolved |
Updated date |
2020-06-18 |
Company comments |
High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |